ニューロフィジオロジー装置と機器の2030年までの世界市場予測：モダリティ別、技術別、用途別、エンドユーザー別、地域別分析

Stratistics MRCによると、世界のニューロフィジオロジー装置と機器市場は2023年に15億2,000万米ドルを占め、2030年には29億5,000万米ドルに達すると予測され、予測期間中のCAGRは9.9％です。

ニューロフィジオロジー装置と機器は、神経系内の電気的活動や反応を測定、監視、刺激、記録するように設計された医療機器・ツールの幅広いカテゴリーです。これらの機器は、脳、脊髄、神経、筋肉の機能を評価し理解するために、様々な臨床、調査、診断用途で利用されています。

全米脳腫瘍協会によると、米国では2021年に約83,570人が脳腫瘍に罹患します。

神経疾患の有病率の上昇

てんかん、パーキンソン病、アルツハイマー病、脳卒中などの神経疾患の有病率が世界的に高まっていることから、高度な診断機器やモニタリング装置の必要性が高まっています。ニューロフィジオロジー装置は、さまざまな状態をタイムリーに特定し、正確に診断し、継続的に監視するために不可欠です。これらの機器により、医療従事者は神経反応、筋機能、脳活動を評価することが可能となり、正確な診断と個別の治療計画に役立っています。さらに、神経疾患の有病率の増加により、患者管理の改善には効果的で信頼性の高いニューロフィジオロジー装置が必要となっています。このため、ヘルスケアにおける神経疾患の拡大する需要に対応するため、業界の研究、革新、最先端技術の開発が推進されています。

高コスト

EEG、MEG、EMGシステムなどの高度なニューロフィジオロジー装置には、多くの場合、多額の初期投資が必要であり、さらにメンテナンス、アップグレード、トレーニングのための継続的な費用もかかります。このような高額なコストは、小規模のクリニックや予算が限られているヘルスケア施設、あるいは資源に制約のある地域では、最先端の機器へのアクセスを制限しています。また、医療従事者がこれらの機器を操作し、データを解釈するための専門的なトレーニングにも費用がかかるため、経済的負担はさらに大きくなります。そのため、市場拡大の需要は減少しています。

AIとデータ分析の統合

AI主導のアルゴリズムとデータ解析は、EEG、MEG、EMGシステムなどの機器によって捕捉された複雑な神経信号からの高度な処理、解釈、意味のある洞察の抽出を可能にします。パターン識別、異常検出、予測モデリングはAIアルゴリズムによって容易になり、神経疾患の診断、追跡、治療計画の精度が向上します。さらに、この統合はニューロフィジオロジー機器の能力と価値を高め、技術革新を促進し、より効果的なデータ処理、リアルタイムフィードバック、より良い意思決定の機会を提供することで、臨床神経学と神経科学を強化します。

複雑さとトレーニング

EEGやMEGシステムのような高度なニューロフィジオロジー装置や機器の操作は複雑であるため、効果的に使用するには専門的なトレーニングが必要です。複雑な神経信号の解釈には専門知識が必要であり、これらの装置の取り扱いに熟練した専門家の不足が課題となっています。包括的なトレーニングプログラムの必要性と、これらの複雑な技術についてヘルスケア担当者を教育するための時間的投資が障壁となり、臨床現場での普及と最適な利用が制限される可能性があり、市場成長の妨げとなっています。

COVID-19の影響

COVID-19の流行は、ニューロフィジオロジー装置と機器市場に多面的な影響を与えました。パンデミックの初期段階では、病院や診療所はリソースの再配分、外来受診の減少、選択的手術のキャンセルなどにより、日常的な治療を提供する上での制約に直面しました。世界のヘルスケアシステムの景気後退と予算制約が資本支出に影響し、新しいニューロフィジオロジー装置への投資が減速する可能性があった。このため、緊急でない症例に対するニューロフィジオロジー機器の導入は一時的に減少しました。課題にもかかわらず、パンデミックは遠隔技術の革新を加速し、ユーザーフレンドリーで遠隔アクセス可能なニューロフィジオロジー装置とソフトウェアの開発を促進しました。

予測期間中、脳電図（EEG）分野が最大になる見込み

脳波計（EEG）分野が最大のシェアを占めると推定されます。脳波（EEG）とは、頭皮に取り付けた小さな金属ディスク（電極）を使って脳の電気的活動を測定する検査です。EEG装置は脳波パターンを捉え、てんかん、睡眠障害、脳損傷など様々な神経疾患の診断に役立ちます。EEG技術の進歩により、ポータブル、ワイヤレス、高解像度のシステムが登場し、リアルタイムのモニタリングと分析が可能になった。EEGは臨床神経学、ニューロフィードバック療法、研究において重要な役割を果たしており、ニューロフィジオロジー機器市場の継続的な革新と普及を促進しています。

予測期間中にCAGRが最も高くなると予測されるのは病院セグメント

病院セグメントは予測期間中に有利な成長が見込まれます。病院では、神経科、集中治療室（ICU）、神経外科などで、診断、モニタリング、治療の目的でさまざまなニューロフィジオロジー装置を利用しています。病院では、ニューロフィジオロジー機器はてんかん、脳卒中、脳腫瘍、神経筋障害の診断に役立っています。これらの装置には、脳波計（EEG）、筋電図（EMG）、脳磁図（MEG）、MRIやCTスキャナーのような神経画像システムが含まれます。病院分野では、神経学的評価と治療における患者ケアと臨床転帰を向上させるため、正確性、信頼性、革新的な機能を重視し、高度なニューロフィジオロジー機器の需要を大きく牽引しています。

最大シェアの地域

アジア太平洋地域は、ヘルスケア支出の増加、神経疾患の有病率の上昇、ヘルスケアインフラの進歩により、予測期間中に最大の市場シェアを占めました。中国、インド、日本、韓国などの国々における患者数の多さと医療投資の増加が、この拡大において重要な役割を果たしています。さらに、アジア太平洋地域は、国際的メーカーとの提携や研究開発への注力により、ニューロフィジオロジー装置と機器の市場拡大に大きく貢献しています。

CAGRが最も高い地域：

北米は、強固なヘルスケアインフラと技術の進歩により、予測期間中に収益性の高い成長が見込まれます。同地域では研究施設やヘルスケア機関が確立しており、技術革新や先進的なニューロフィジオロジー機器の採用に拍車をかけています。米国やカナダなどの国々では、神経疾患の診断にEEG、EMG、神経画像診断装置の需要が大きいです。さらに、神経疾患の有病率の増加、人口の高齢化、個別化医療の重視は、北米におけるニューロフィジオロジー技術の採用と市場拡大におけるこの地域のリーダーシップに寄与しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 技術分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のニューロフィジオロジー装置と機器市場：モダリティ別

• ポータブル
• スタンドアロン

第6章 世界のニューロフィジオロジー装置と機器市場：技術別

• 筋電図検査（EMG）
• 皮質電図検査（ECoG）
• 脳波検査（EEG）
• 誘発電位（EP）
• その他の技術

第7章 世界のニューロフィジオロジー装置と機器市場：用途別

• 睡眠障害
• パーキンソン病
• てんかん
• アルツハイマー病
• その他の用途

第8章 世界のニューロフィジオロジー装置と機器市場：エンドユーザー別

• 外来手術センター
• 病院
• その他のエンドユーザー

第9章 世界のニューロフィジオロジー装置と機器市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Medtronic PLC.
• Dr. Langer Medical Gmbh
• Nihon Kohden Corporation
• Natus Medical Incorporated
• NuVasiveInc.
• Inomed Medizintechnik
• Axon Healthcare Ltd.
• Neurosign
• Bovie Medical Corporation
• Neurowave Systems
• Koninklijke Philips N.V.
• Cadwell Industries, Inc.
• Electrical Geodesics Incorporated
• Advanced Brain Monitoring, Inc.

List of Tables

• Table 1 Global Neurophysiology Devices and Equipment Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 3 Global Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 4 Global Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 5 Global Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 6 Global Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 7 Global Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 8 Global Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 9 Global Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 10 Global Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 11 Global Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 13 Global Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 14 Global Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 15 Global Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 16 Global Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 17 Global Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 18 Global Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 19 Global Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 20 Global Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 21 North America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 23 North America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 24 North America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 25 North America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 26 North America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 27 North America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 28 North America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 29 North America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 30 North America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 31 North America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 32 North America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 33 North America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 34 North America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 35 North America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 36 North America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 37 North America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 38 North America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 39 North America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 40 North America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 41 Europe Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 43 Europe Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 44 Europe Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 45 Europe Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 46 Europe Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 47 Europe Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 48 Europe Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 49 Europe Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 50 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 51 Europe Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 52 Europe Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 53 Europe Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 54 Europe Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 55 Europe Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 56 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 57 Europe Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 58 Europe Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 59 Europe Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 60 Europe Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 63 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 64 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 65 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 66 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 67 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 68 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 69 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 70 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 71 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 72 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 73 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 74 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 75 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 76 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 77 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 78 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 79 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 80 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 81 South America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 83 South America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 84 South America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 85 South America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 86 South America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 87 South America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 88 South America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 89 South America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 90 South America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 91 South America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 92 South America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 93 South America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 94 South America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 95 South America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 96 South America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 97 South America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 98 South America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 99 South America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 100 South America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 101 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
• Table 103 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
• Table 104 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
• Table 105 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
• Table 106 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
• Table 107 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
• Table 108 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
• Table 109 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
• Table 110 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 111 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
• Table 112 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
• Table 113 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
• Table 114 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
• Table 115 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
• Table 116 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 117 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
• Table 118 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 119 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 120 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Neurophysiology Devices and Equipment Market is accounted for $1.52 billion in 2023 and is expected to reach $2.95 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Neurophysiology devices and equipment are a broad category of medical instruments and tools designed to measure, monitor, stimulate, or record the electrical activity and responses within the nervous system. These devices are utilised in various clinical, research, and diagnostic applications to assess and understand the functioning of the brain, spinal cord, nerves, and muscles.

According to the National Brain Tumour Society, approximately 83,570 persons in the United States will be affected by Brain Tumours in 2021.

Market Dynamics:

Driver:

Rising prevalence of neurological disorders

The increasing prevalence of neurological disorders such as epilepsy, Parkinson's, Alzheimer's, and stroke worldwide has led to a greater need for sophisticated diagnostic instruments and monitoring apparatus. Neurophysiology equipment is essential for the timely identification, precise diagnosis, and ongoing surveillance of various conditions. They make it possible for medical practitioners to evaluate neural responses, muscle function, and brain activity, which helps with accurate diagnosis and individualised treatment plans. Moreover, the growing prevalence of neurological diseases makes effective and dependable neurophysiology devices necessary for improved patient management. This is propelling the industry's research, innovation, and development of cutting-edge technologies to meet the expanding demands of neurological conditions in healthcare.

Restraint:

High cost

Advanced neurophysiology devices, such as EEG, MEG, and EMG systems, often require substantial initial investments, coupled with ongoing expenses for maintenance, upgrades, and training. These elevated costs limit access to state-of-the-art equipment for smaller clinics, healthcare facilities with limited budgets, or regions with constrained resources. Also, the expense of specialised training for healthcare professionals to operate and interpret data from these devices further adds to the financial burden. Thus, there is a decreasing demand for market expansion.

Opportunity:

Integration of AI and data analytics

AI-driven algorithms and data analytics enable advanced processing, interpretation, and extraction of meaningful insights from complex neural signals captured by devices like EEG, MEG, and EMG systems. Pattern identification, anomaly detection, and predictive modelling are made easier by AI algorithms, which improve the precision of neurological disease diagnosis, tracking, and treatment planning. Moreover, this integration enhances the capabilities and value of neurophysiology equipment, promotes innovation, and enhances clinical neurology and neuroscience by providing opportunities for more effective data processing, real-time feedback, and better decision-making.

Threat:

Complexity and training

The complexity of operating sophisticated neurophysiology devices and equipment, such as EEG or MEG systems, requires specialised training for effective use. Interpretation of complex neural signals demands expertise, posing a challenge due to a shortage of skilled professionals proficient in handling these devices. The need for comprehensive training programmes and the time investment to educate healthcare personnel about these intricate technologies create a barrier, potentially limiting their widespread adoption and optimal utilisation in clinical settings, thereby hindering market growth.

COVID-19 Impact

The COVID-19 pandemic has had a multifaceted impact on the neurophysiology devices and equipment market. During the initial phases of the pandemic, hospitals and clinics faced constraints in providing routine care due to resource reallocation, reduced outpatient visits, and elective procedure cancellations. Economic downturns and budget constraints in healthcare systems globally affected capital expenditure, potentially slowing down investments in new neurophysiology equipment. This led to a temporary decline in the adoption of neurophysiology devices for non-urgent cases. Despite challenges, the pandemic accelerated innovation in remote technologies, fostering the development of user-friendly, remote-accessible neurophysiology devices and software.

The Electroencephalography (EEG) segment is expected to be the largest during the forecast period

The Electroencephalography (EEG) segment is estimated to hold the largest share. An electroencephalogram (EEG) is a test that measures electrical activity in the brain using small metal discs (electrodes) attached to the scalp. EEG devices capture brainwave patterns, aiding in the diagnosis of various neurological conditions such as epilepsy, sleep disorders, and brain injuries. Advancements in EEG technology have led to portable, wireless, and high-resolution systems, enabling real-time monitoring and analysis. EEG plays a crucial role in clinical neurology, neurofeedback therapies, and research, driving continuous innovation and adoption in the market for neurophysiology devices.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals utilise various neurophysiology devices for diagnostics, monitoring, and treatment purposes in neurology departments, intensive care units (ICUs), and neurosurgery units. In hospitals, neurophysiology equipment aids in diagnosing epilepsy, stroke, brain tumours, and neuromuscular disorders. These devices include electroencephalography (EEG), electromyography (EMG), magnetoencephalography (MEG), and neuroimaging systems like MRI and CT scanners. The hospital segment drives significant demand for advanced neurophysiology equipment, emphasising accuracy, reliability, and innovative features to enhance patient care and clinical outcomes in neurological assessments and treatments.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to increasing healthcare expenditure, the rising prevalence of neurological disorders, and advancements in healthcare infrastructure. The significant patient populations and increasing healthcare investments in nations like China, India, Japan, and South Korea play a crucial role in this expansion. Additionally, the Asia-Pacific area makes a substantial contribution to the growing market for neurophysiology devices and equipment due to partnerships with international manufacturers and a focus on research and development.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to robust healthcare infrastructure and technological advancements. The regions well-established research facilities and healthcare institutions fuel innovation and the adoption of advanced neurophysiology devices. Countries like the United States and Canada witness substantial demand for EEG, EMG, and neuroimaging equipment for diagnosing neurological disorders. Moreover, the increasing prevalence of neurological conditions, ageing population, and emphasis on personalised medicine contribute to the region's leadership in neurophysiology technology adoption and market expansion in North America.

Key players in the market:

Some of the key players in the Neurophysiology Devices and Equipment Market include Medtronic PLC., Dr. Langer Medical Gmbh, Nihon Kohden Corporation, Natus Medical Incorporated, NuVasiveInc., Inomed Medizintechnik, Axon Healthcare Ltd., Neurosign, Bovie Medical Corporation, Neurowave Systems, Koninklijke Philips N.V., Cadwell Industries, Inc., Electrical Geodesics Incorporated, and Advanced Brain Monitoring, Inc.

Key Developments:

In December 2022, Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions. Exciting combination of product solutions will create a leading neurodiagnostic and neuromonitoring portfolio supported by an organization of knowledgeable and passionate experts.

In October 2022, Nihon Kohden, a U.S. market leader in precision medical products and services, announced the launch of the Smart Cable™ NMT Pod and disposable electrode, allowing clinicians to monitor neuromuscular blockade with confidence. The new device allows clinicians to objectively monitor the patient's depth of paralysis during surgery when a neuromuscular blockade agent (NMBA), either non-depolarizing or depolarizing, is administered to the patient.

Modalities Covered:

• Portable
• Standalone

Technologies Covered:

• Electromyography (EMG)
• Electrocorticography (ECoG)
• Electroencephalography (EEG)
• Evoked potential (EP)
• Other Technologies

Applications Covered:

• Sleep Disorders
• Parkinson's Disease
• Epilepsy
• Alzheimer's Disease
• Other Applications

End Users Covered:

• Ambulatory Surgical Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Neurophysiology Devices and Equipment Market, By Modality

• 5.1 Introduction
• 5.2 Portable
• 5.3 Standalone

6 Global Neurophysiology Devices and Equipment Market, By Technology

• 6.1 Introduction
• 6.2 Electromyography (EMG)
• 6.3 Electrocorticography (ECoG)
• 6.4 Electroencephalography (EEG)
• 6.5 Evoked potential (EP)
• 6.6 Other Technologies

7 Global Neurophysiology Devices and Equipment Market, By Application

• 7.1 Introduction
• 7.2 Sleep Disorders
• 7.3 Parkinson's Disease
• 7.4 Epilepsy
• 7.5 Alzheimer's Disease
• 7.6 Other Applications

8 Global Neurophysiology Devices and Equipment Market, By End User

• 8.1 Introduction
• 8.2 Ambulatory Surgical Centers
• 8.3 Hospitals
• 8.4 Other End Users

9 Global Neurophysiology Devices and Equipment Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Medtronic PLC.
• 11.2 Dr. Langer Medical Gmbh
• 11.3 Nihon Kohden Corporation
• 11.4 Natus Medical Incorporated
• 11.5 NuVasiveInc.
• 11.6 Inomed Medizintechnik
• 11.7 Axon Healthcare Ltd.
• 11.8 Neurosign
• 11.9 Bovie Medical Corporation
• 11.10 Neurowave Systems
• 11.11 Koninklijke Philips N.V.
• 11.12 Cadwell Industries, Inc.
• 11.13 Electrical Geodesics Incorporated
• 11.14 Advanced Brain Monitoring, Inc.